Key Role for Activin B in Cellular Transformation after Loss of the von Hippel-Lindau Tumor Suppressor
Open Access
- 1 April 2009
- journal article
- research article
- Published by Taylor & Francis Ltd in Molecular and Cellular Biology
- Vol. 29 (7), 1707-1718
- https://doi.org/10.1128/mcb.01184-07
Abstract
The von Hippel-Lindau tumor suppressor gene (VHL) is mutated in clear cell renal cell carcinomas (RCC), leading to the activation of hypoxia-inducible factor (HIF)-mediated gene transcription. Several VHL/HIF targets, such as glycolysis, angiogenesis, cell growth, and chemotaxis of tumor cells, have been implicated in the transformed phenotype of RCC-regulating properties. Here, we show that VHL suppresses key features of cell transformation through downregulation of the HIF-dependent expression of activin B, a member of the transforming growth factor β superfamily. Activin B expression is repressed by restoration of VHL in VHL-deficient RCC cells and upregulated by hypoxia. RCC tumor samples show increased expression of activin B compared to that in the normal kidney. VHL increases cell adhesion to the extracellular matrix, promotes cell flattening, and reduces invasiveness. These effects are completely phenocopied by RNA interference-mediated knockdown of activin B and reverted by treatment with recombinant activin B. Finally, knockdown of activin B reduces tumor growth of RCC cells in nude mice. Our data indicate that activin B is a key mediator of VHL/HIF-induced transformation in RCC.Keywords
This publication has 36 references indexed in Scilit:
- VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and SnailMolecular and Cellular Biology, 2007
- The von Hippel–Lindau tumor suppressor gene product represses oncogenic β-catenin signaling in renal carcinoma cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- A Role for the Mitogen-activated Protein Kinase Kinase Kinase 1 in Epithelial Wound HealingMolecular Biology of the Cell, 2006
- Characterization of a von Hippel Lindau Pathway Involved in Extracellular Matrix Remodeling, Cell Invasion, and AngiogenesisCancer Research, 2006
- Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor GrowthPLoS Biology, 2003
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- A role for MEK kinase 1 in TGF- /activin-induced epithelium movement and embryonic eyelid closureThe EMBO Journal, 2003
- Hypoxia promotes invasive growth by transcriptional activation of the met protooncogeneCancer Cell, 2003
- VHL Induces Renal Cell Differentiation and Growth Arrest through Integration of Cell-Cell and Cell-Extracellular Matrix SignalingMolecular and Cellular Biology, 2001
- Two messenger ribonucleic acids encoding the common beta B-chain of inhibin and activin have distinct 5'-initiation sites and are differentially regulated in rat granulosa cellsEndocrinology, 1994